Briacell TherapeuticsBCTX
13F holders, Q1 2024 (March 31)19holders
2famous investors
$2.91avg. 13F price*
At the end of Q1 2024, 19 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings. The largest holders were Lynwood Capital Management Inc. ($4.6M), Bank of Montreal ($521K) and Redmond Asset Management, LLC ($381K). 2 famous investors held it, including Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio) and Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930109
- Latest filing quarter
- Q4 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $98K |
| Exits | 6 | $2.0M |
Ownership 19 holders
| Lynwood Capital Management Inc. | 27.45% | Add +1.1% | 1,597,750 | $4.6M |
| Bank of Montreal | 0.00% | Add +148.1% | 134,241 | $521K |
| Redmond Asset Management, LLC | 0.12% | Reduce -0.4% | 133,069 | $381K |
| K.J. Harrison & Partners Inc | 0.04% | Add +7.8% | 87,044 | $249K |
| Onyx Bridge Wealth Group LLC | 0.02% | Add +66.7% | 50,000 | $109K |
| Summit Trail Advisors, LLC | 0.00% | No change | 35,000 | $100K |
| Sabby Management, LLC | 0.71% | New | 34,222 | $98K |
| Morgan Stanley | 0.00% | Reduce -63.5% | 23,664 | $68K |
| Bank of America Corp. | 0.00% | Add +1.1% | 17,999 | $51K |
| TD Waterhouse Canada Inc. | 0.00% | No change | 12,050 | $41K |
| HighTower Advisors, LLC | 0.00% | Reduce -9.1% | 14,450 | $41K |
| Susquehanna International Group, LLP | 0.00% | Reduce -80.2% | 12,357 | $35K |
| Renaissance Technologies | 0.00% | Add +11.9% | 12,200 | $35K |
| Concord Wealth Partners | 0.01% | No change | 10,775 | $31K |
| Citadel Advisors | 0.00% | Reduce -57.0% | 6,427 | $18K |
| National Bank of Canada | 0.00% | No change | 7,500 | $17K |
| Royal Bank of Canada | 0.00% | Reduce -80.7% | 3,600 | $10K |
| Osaic Holdings, Inc. | 0.00% | Add +8500.0% | 1,032 | $3K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +49.0% | 787 | $2K |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.